What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Disease
Dennis W. Dickson focuses on Pathology, Alzheimer's disease, Dementia, Genetics and Disease.
His Pathology research focuses on Progressive supranuclear palsy, Frontotemporal dementia, Neuropathology, Parkinsonism and Neurofibrillary tangle.
His work investigates the relationship between Frontotemporal dementia and topics such as Amyotrophic lateral sclerosis that intersect with problems in C9orf72 Protein.
Tau protein and Neurodegeneration is closely connected to Neuroscience in his research, which is encompassed under the umbrella topic of Neuropathology.
His Alzheimer's disease research is multidisciplinary, incorporating perspectives in Hippocampal sclerosis, Autopsy and Degenerative disease.
His work in Dementia addresses subjects such as Psychiatry, which are connected to disciplines such as Pediatrics.
His most cited work include:
- Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium (3883 citations)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop (3554 citations)
- Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS (3097 citations)
What are the main themes of his work throughout his whole career to date?
Dennis W. Dickson mainly focuses on Pathology, Disease, Dementia, Alzheimer's disease and Neuroscience.
His study in Pathology focuses on Progressive supranuclear palsy, Frontotemporal lobar degeneration, Atrophy, Frontotemporal dementia and Neuropathology.
His study in Progressive supranuclear palsy is interdisciplinary in nature, drawing from both Tau protein and Tauopathy.
His studies deal with areas such as Genetics and Pathological as well as Disease.
His Dementia research includes themes of Hippocampal sclerosis, Pediatrics and Parkinsonism.
His Alzheimer's disease research integrates issues from Apolipoprotein E and Degenerative disease.
He most often published in these fields:
- Pathology (49.47%)
- Disease (18.15%)
- Dementia (17.31%)
What were the highlights of his more recent work (between 2016-2021)?
- Pathology (49.47%)
- Disease (18.15%)
- Progressive supranuclear palsy (13.95%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Pathology, Disease, Progressive supranuclear palsy, Dementia and Neuropathology.
His study in Atrophy, Frontotemporal lobar degeneration, Parkinsonism, Frontotemporal dementia and Neurofibrillary tangle are all subfields of Pathology.
He focuses mostly in the field of Frontotemporal lobar degeneration, narrowing it down to topics relating to C9orf72 and, in certain cases, Neurodegeneration, RNA, Cell biology and C9orf72 Protein.
His work carried out in the field of Disease brings together such families of science as Neuroscience and Cohort.
His Progressive supranuclear palsy research focuses on Tauopathy and how it connects with Tau protein.
The Dementia study combines topics in areas such as Allele and Pediatrics.
Between 2016 and 2021, his most popular works were:
- Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium (1355 citations)
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria (612 citations)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (429 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Disease
His primary scientific interests are in Pathology, Disease, Progressive supranuclear palsy, Dementia and Tauopathy.
His research integrates issues of Hippocampal sclerosis and Hippocampus in his study of Pathology.
Particularly relevant to Alzheimer's disease is his body of work in Disease.
His study in Alzheimer's disease is interdisciplinary in nature, drawing from both Dementia with Lewy bodies and Cognitive decline.
The study incorporates disciplines such as Tau pathology, Genome-wide association study and Neuroscience in addition to Progressive supranuclear palsy.
As a member of one scientific family, Dennis W. Dickson mostly works in the field of Dementia, focusing on Apolipoprotein E and, on occasion, Oncology and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
